Guarnera, Luca; Ahmed, Arooj; Bravo-Pérez, Carlos; Ogbue, Olisaemeka-D; D'Addona, Matteo; Brady, Zachary; Unlu, Serhan; Haddad, Christopher; Mandala, Aashray; Durmaz, Arda; Gurnari, Carmelo; Visconte, Valeria; Maciejewski, Jaroslaw-P
(WILEY, 2025-07)
Anti-thymocyte globulin in multi-refractory immune-mediated cytopenia is an effective treatment, with response rate as high as 65%. Younger patients, presenting with thrombocytopenia or neutropenia, and those with LGL and ...